Kirstiema Cowan
Family · Hampstead, NCNPI 1003230848
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 9 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $134 and has fallen 55.3% since, to $60 in 2024. That places this record below the midpoint for family clinicians in NC, where the typical reported total is $325.
Across 14 payments — averaging $18.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zealand Pharma US, Inc.$50
- AbbVie$47
- GSK$42
- Sanofi Pasteur Inc.$31
- Novo Nordisk$23
- Amgen$18
- plus $47 from 3 others
What the payments were for
- Food & beverage$257100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zealand Pharma US, Inc. | 2 | $50 |
| AbbVie | 3 | $47 |
| GSK | 2 | $42 |
| Sanofi Pasteur Inc. | 2 | $31 |
| Novo Nordisk | 1 | $23 |
| Amgen | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Lilly USA, LLC | 1 | $15 |
| Pfizer | 1 | $13 |
How this compares
$257 in reported general payments places this provider in the 45th percentile of 4,522 family providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 59 | $470 |
| Gabapentin | 20 | $187 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 12 | $135 |
| Amlodipine Besylate | 16 | $91 |
| Methylprednisolone | 11 | $83 |
| Atorvastatin Calcium | 18 | $62 |
| Losartan Potassium | 13 | $56 |
| Lisinopril | 13 | $55 |
Paid to pharmacies, not to this prescriber.
Other family in Hampstead
- Leslie ByrneFayetteville$482K
- Michele CerraRaleigh$332K
- Anne LakeArchdale$306K
- Carrie PettitRaleigh$298K
- Nicole RothmanDurham$268K
- Meredith LeaYanceyville$253K
- Jennifer GibbsRaleigh$216K
- Juanita PerkinsDurham$213K
- Teresa DossWilmington$137K
- Debra ScottCharlotte$129K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.